![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Rhinostics’ Automated Nasal Swab for COVID-19 Testing Approved by Health Canada
Rhinostics’ Automated Nasal Swab for COVID-19 Testing Approved by Health Canada
Waltham, Mass.-based Rhinostics has received Health Canada’s approval for its RHINOstic automated nasal swab system for collection of samples for COVID-19 tests.
The system features a polypropylene-based swab that is placed into a dry transport tube designed for processing using an automated workflow. The hydrophobic material, which does not require a viral transport medium, helps ensure complete sample elution — the extraction of the absorbed substance using a solvent.
The swabs work with a variety of automated decappers to create hands-free workflows from the point the bar-coded sample enters the lab through decapping and processing into assay microplates, removing labor and errors, the company said.
Upcoming Events
-
21Oct